Codexis to Report Third Quarter 2026 Financial Results on November 12
Stocks in this Quantisnow insightIndustrials
Historical context for CDXS
Across the 20 sessions after earlier CDXS headlines, the stock closed higher 13 times and lower 7 times, with a median move of 3.4% in either direction. This shows timing only: many things move a stock in a session, and these figures do not show that any headline caused a move.
| Session | Earlier headline | CDXS | SPY |
|---|---|---|---|
| Sep 28, 2026 | Codexis Enters into an Agreement with Pioneering siRNA Drug Innovator to Leverage the ECO Synthesis Manufacturing Platform to Create Stereo-defined siRNA | +3.0% | -0.7% |
| Aug 27, 2026 | Codexis to Participate in Cantor Global Healthcare Conference 2026 | +0.6% | +0.7% |
| Aug 12, 2026 | Codexis Reports Second Quarter 2026 Financial Results | +8.1% | +0.3% |
| Aug 3, 2026 | Codexis Appoints David Butler, PhD, to Strategic Advisory Board | +3.6% | +1.4% |
| Jul 28, 2026 | Codexis to Report Second Quarter 2026 Financial Results on August 11 | -3.2% | +0.2% |
| Jul 24, 2026 | Codexis Announces Pricing of Public Offering of Common Stockand 1 other headline that session | -25.6% | +0.1% |
Quantisnow market dataNASDAQ
CDXS
Codexis Inc.
- Market cap
- 30-day
- Sector
- Industrials
- Industry
- Major Chemicals
- Listed since
- 2010
Get push alerts for CDXS
Full CDXS profile on Quantisnow Follow CDXS and get a push notification the moment its next story breaks.